Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial
National Institute of Allergy and Infectious Diseases (NIAID)
Laura C Steinhardt; Titus K Kwambai; Martina Oneko; Eunice Ouma; Ruth Njoroge; Viviane Callier; Zonghui Hu; Julie R Gutman; Reuben Yego; Kephas Otieno; Kelvin Onoka; Lilian Otieno; Kennedy Oduol; Leonid Serebryannyy; Bob C Lin; Will Adams; Somia Hickman; Anne C Preston; Kevin Carlton; Michael Holdsworth; Yan Xiao; Feiko O Ter Kuile; Wycliffe Odongo; Sean C Murphy; Tuan M Tran; Simon Kariuki; Peter D Crompton; Robert A Seder; Kenya Malaria mAb Trials Team
Office of Biostatistics Research, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.